Order Online! Now! Get your $50 coupon for online order.
Order Online! Now! Get your $50 coupon for online order.
Our limited edition HOLIDAYS LLAMA is here! Place any order now to recieve one!
Earn Loyalty Rewards! Up to $155 Amazon Gift Card
Time Limited Offer: Welcome Gift for New Customers !
Time Limited Offer: Welcome Gift for New Customers !
Project Name | Modality | Therapeutic Area | Indications | Stage | Right Available |
IL10 / IL10RA mAb | Monospecific antibody | Infectious and parasitic diseases | Immunodeficiencies | PCC | Global |
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CRS-B005 | Human | ClinMax™ Human IL-10 ELISA Kit | |||
IL0-C4248 | Cynomolgus | Cynomolgus IL-10 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
IL0-H5219 | Human | Human IL-10 Protein, premium grade | ![]() |
![]() ![]() |
![]() ![]() |
IL0-M4248 | Mouse | Mouse IL-10 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
IL0-H4248 | Human | Human IL-10 Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
Human IL-10, premium grade (Cat. No. IL0-H5219) Inhibits the IL‐6 secretion in RAW264.7 cell line. The specific activity of Human IL-10 Protein, premium grade>1.00*10^7 IU/mg, which is calibrated against human IL- 10 WHO International Standard (NIBSC code: 93/722) (QC tested).
Immobilized Human IL-10, premium grade (Cat. No. IL0-H5219) at 5 μg/mL (100 μL/well) can bind Cynomolgus IL-10 R alpha Protein, Fc Tag (Cat. No. ILR-C5256) with a linear range of 0.1-2 ng/mL (QC tested).
The purity of Human IL-10, premium grade (Cat. No. IL0-H5219) is more than 90% and the molecular weight of this protein is around 32-42 kDa verified by SEC-MALS.
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Recombinant anti-InE monoclonal antibody | CmAb-(IL10)2 | Phase 1 Clinical | Dingfu Biotarget Co Ltd | Solid tumours | Details |
WP-1303 (worgpharma) | ATX-MS-1467; ATX-MS-01; M-2736; WP-1303; MSC-2358825A | Phase 2 Clinical | Apitope Technology | Multiple Sclerosis, Relapsing-Remitting; Multiple Sclerosis; Multiple Myeloma | Details |
KLS-2031 | KLS-2031 | Phase 2 Clinical | Kolon Life Science. Inc | Radiculopathy | Details |
This web search service is supported by Google Inc.